0.012501 0.000000 0.000000 0.000000 0.012501 0.000000 0.000000 0.000000 0.012501 0.00000 0.00000 0.00000 Yadav, M.K. Leman, L.J. Price, D.J. Brooks 3rd, C.L. Stout, C.D. Ghadiri, M.R. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 48 90.00 90.00 90.00 79.992 79.992 79.992 C2 H4 O 44.053 ACETYL GROUP non-polymer C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 45 4463 4473 10.1021/bi060092q 16584182 Coiled coils at the edge of configurational heterogeneity. Structural analyses of parallel and antiparallel homotetrameric coiled coils reveal configurational sensitivity to a single solvent-exposed amino acid substitution. 2006 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 180.0 1 CCD 2005-07-12 ADSC CCD SINGLE WAVELENGTH M x-ray 1 0.979 1.0 BL11-1 SSRL 0.979 SYNCHROTRON SSRL BEAMLINE BL11-1 4030.802 General control protein GCN4 RESIDUES 249-281 YES 2 syn polymer 18.015 water 18 nat water Amino acid biosynthesis regulatory protein no yes (ACE)RMKQIEDKLEEILSKLYHISNELARIKKLLGER XRMKQIEDKLEEILSKLYHISNELARIKKLLGER A,B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n 1 2.7 54 0.00 2M NACL, 10% PEG 6K, pH 0.00 audit_author citation citation_author entity entity_name_com entity_src_nat pdbx_entity_src_syn struct_ref struct_ref_seq struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Source and taxonomy Structure summary 1 0 2006-04-06 1 1 2011-05-08 1 2 2011-07-13 1 3 2018-11-07 _audit_author.name _citation.page_last _citation.pdbx_database_id_DOI _citation.title _citation_author.name _entity.pdbx_description _entity.src_method _entity_name_com.name HELIX CAPPING IN THE GCN4 LEUCINE ZIPPER GCN4 LEUCINE ZIPPER COMPLEXED WITH SPECIFIC ATF/CREB SITE DEOXYRIBONUCLEIC ACID ATOMIC STRUCTURE OF THE ECTODOMAIN FROM HIV -1 GP41 THE STRUCTURE OF AN HIV-1 SPECIFIC CELL ENTRY INHIBITOR INCOMPLEX WITH THE HIV-1 GP41 TRIMERIC CORE GCN4 LEUCINE ZIPPER CORE MUTANT P-LI GCN4 LEUCINE ZIPPER CORE MUTANT P-LI HUMAN VIMENTIN COIL 2B FRAGMENT LINKED TO GCN4 LEUCINE ZIPPER (Z2B) CRYSTAL STRUCTURE OF C14LINKMID/IQN17: A CROSS-LINKED INHIBITOR OF HIV-1 ENTRY BOUND TO THE GP41 HYDROPHOBIC POCKET GLYTM1BZIP: A CHIMERIC PEPTIDE MODEL OF THE N-TERMINUS OF ARAT SHORT ALPHA TROPOMYOSIN WITH THE N-TERMINUS ENCODED BYEXON 1B COILED COIL TRIMER GCN4-PVLS SER AT BURIED D POSITION GCN4-PVLT COILED-COIL TRIMER WITH THREONINE AT THE D(12)POSITION GCN4-PVTL COILED-COIL TRIMER WITH THREONINE AT THE A(16)POSITION GCN4-PVSL COILED-COIL TRIMER WITH SERINE AT THE A(16)POSITION CRYSTAL STRUCTURE OF THE C-TERMINAL REGION OF STRIATEDMUSCLE ALPHA-TROPOMYOSIN AT 2.7 ANGSTROM RESOLUTION PLACEMENT OF THE STRUCTURAL PROTEINS IN SINDBIS VIRUS CRYSTAL STRUCTURE OF A ZIF23-GCN4 CHIMERA BOUND TO DNA VISUALIZING AN UNSTABLE COILED COIL: THE CRYSTAL STRUCTUREOF AN N-TERMINAL SEGMENT OF THE SCALLOP MYOSIN ROD CRYSTAL STRUCTURE OF GCN4-PIQ, A TRIMERIC COILED COIL WITH BURIED POLAR RESIDUES GCN4-LEUCINE ZIPPER CORE MUTANT AS N16A TRIGONAL AUTOMATICSOLUTION ANTIPARALLEL TRIMER OF GCN4-LEUCINE ZIPPER CORE MUTANT ASN16A TETRAGONAL AUTOMATIC SOLUTION ANTIPARALLEL TRIMER OF GCN4-LEUCINE ZIPPER CORE MUTANT ASN16A TRIGONAL FORM ANTIPARALLEL TRIMER OF GCN4-LEUCINE ZIPPER CORE MUTANT ASN16A TETRAGONAL FORM GCN4-LEUCINE ZIPPER CORE MUTANT AS N16A COMPLEXED WITH BENZENE TMZIP: A CHIMERIC PEPTIDE MODEL OF THE N- TERMINUS OF ALPHA TROPOMYOSIN, NMR, 15 STRUCTURES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES AN ANTI-PARALLEL FOUR HELIX BUNDLE MUTANT PLI-E20C AN ANTI-PARALLEL FOUR HELIX BUNDLE ( ACETIMIDE MODIFICATION). AN ANTI-PARALLEL FOUR HELIX BUNDLE. ABA DOES NOT AFFECT TOPOLOGY OF PLI. AN ANTI-PARALLEL FOUR HELIX BUNDLE AN ANTI-PARALLEL FOUR HELIX BUNDLE AN ANTI-PARALLEL TO PARALLEL SWITCH. GCN4 (BASIC REGION, LEUCINE ZIPPER) COMPLEX WITH AP-1 DEOXYRIBONUCLEIC ACID GCN4-LEUCINE ZIPPER CORE MUTANT ASN16ABA IN THE DIMERIC STATE GCN4-LEUCINE ZIPPER CORE MUTANT ASN16ABA IN THE TRIMERIC STATE GCN4-LEUCINE ZIPPER CORE MUTANT ASN16LYS IN THE DIMERIC STATE GCN4-LEUCINE ZIPPER CORE MUTANT ASN16GLN IN THE DIMERIC STATE GCN4-LEUCINE ZIPPER CORE MUTANT ASN16GLN IN THE TRIMERIC STATE LEUCINE ZIPPER MONOMER (NMR, 20 STRUCTURES) ANTIPARALLEL FOUR-STRANDED COILED COIL SPECIFIED BY A 3-3-1HYDROPHOBIC HEPTAD REPEAT ANTIPARALLEL FOUR-STRANDED COILED COIL SPECIFIED BY A 3-3-1HYDROPHOBIC HEPTAD REPEAT PLI MUTANT E20C L16G Y17H, ANTIPARALLEL ANTIPARALLEL CONFIGURATION OF PLI E20S PLI E20C IS ANTIPARALLEL GCN4 BASIC DOMAIN, LEUCINE ZIPPER COMPLEXED WITH ATF/CREB SITE DEOXYRIBONUCLEIC ACID GCN4 LEUCINE ZIPPER PDBE Y PDBE 2006-01-16 REL HOH water 4932 Baker's yeast Saccharomyces cerevisiae sample 1 34 ENGINEERED RESIDUE IN CHAIN A, GLU 268 TO SER ENGINEERED RESIDUE IN CHAIN B, GLU 268 TO SER HOH 2001 2 HOH HOH 2001 A HOH 2002 2 HOH HOH 2002 A HOH 2003 2 HOH HOH 2003 A HOH 2004 2 HOH HOH 2004 A HOH 2005 2 HOH HOH 2005 A HOH 2006 2 HOH HOH 2006 A HOH 2007 2 HOH HOH 2007 A HOH 2008 2 HOH HOH 2008 A HOH 2009 2 HOH HOH 2009 A HOH 2010 2 HOH HOH 2010 A HOH 2011 2 HOH HOH 2011 A HOH 2012 2 HOH HOH 2012 A HOH 2001 2 HOH HOH 2001 B HOH 2002 2 HOH HOH 2002 B HOH 2003 2 HOH HOH 2003 B HOH 2004 2 HOH HOH 2004 B HOH 2005 2 HOH HOH 2005 B HOH 2006 2 HOH HOH 2006 B n 1 0 A n 2 1 A MET 2 n 3 MET 2 A LYS 3 n 4 LYS 3 A GLN 4 n 5 GLN 4 A ILE 5 n 6 ILE 5 A GLU 6 n 7 GLU 6 A ASP 7 n 8 ASP 7 A LYS 8 n 9 LYS 8 A LEU 9 n 10 LEU 9 A GLU 10 n 11 GLU 10 A GLU 11 n 12 GLU 11 A ILE 12 n 13 ILE 12 A LEU 13 n 14 LEU 13 A SER 14 n 15 SER 14 A LYS 15 n 16 LYS 15 A LEU 16 n 17 LEU 16 A TYR 17 n 18 TYR 17 A HIS 18 n 19 HIS 18 A ILE 19 n 20 ILE 19 A SER 20 n 21 SER 20 A ASN 21 n 22 ASN 21 A GLU 22 n 23 GLU 22 A LEU 23 n 24 LEU 23 A ALA 24 n 25 ALA 24 A ARG 25 n 26 ARG 25 A ILE 26 n 27 ILE 26 A LYS 27 n 28 LYS 27 A LYS 28 n 29 LYS 28 A LEU 29 n 30 LEU 29 A LEU 30 n 31 LEU 30 A GLY 31 n 32 GLY 31 A GLU 32 n 33 GLU 32 A n 34 33 A n 1 0 B n 2 1 B MET 2 n 3 MET 2 B LYS 3 n 4 LYS 3 B GLN 4 n 5 GLN 4 B ILE 5 n 6 ILE 5 B GLU 6 n 7 GLU 6 B ASP 7 n 8 ASP 7 B LYS 8 n 9 LYS 8 B LEU 9 n 10 LEU 9 B GLU 10 n 11 GLU 10 B GLU 11 n 12 GLU 11 B ILE 12 n 13 ILE 12 B LEU 13 n 14 LEU 13 B SER 14 n 15 SER 14 B LYS 15 n 16 LYS 15 B LEU 16 n 17 LEU 16 B TYR 17 n 18 TYR 17 B HIS 18 n 19 HIS 18 B ILE 19 n 20 ILE 19 B SER 20 n 21 SER 20 B ASN 21 n 22 ASN 21 B GLU 22 n 23 GLU 22 B LEU 23 n 24 LEU 23 B ALA 24 n 25 ALA 24 B ARG 25 n 26 ARG 25 B ILE 26 n 27 ILE 26 B LYS 27 n 28 LYS 27 B LYS 28 n 29 LYS 28 B LEU 29 n 30 LEU 29 B LEU 30 n 31 LEU 30 B GLY 31 n 32 GLY 31 B GLU 32 n 33 GLU 32 B n 34 33 B author_and_software_defined_assembly PQS 4 tetrameric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 1.0000000000 0.0000000000 18_545 -x+1/4,z-1/4,y+1/4 crystal symmetry operation 19.9980000000 -19.9980000000 19.9980000000 1 A HOH 2011 C HOH 1 A N MET 2 A N MET 3 1 Y 1 A CG MET 2 A CG MET 3 1 Y 1 A SD MET 2 A SD MET 3 1 Y 1 A CE MET 2 A CE MET 3 1 Y 1 A CB LYS 3 A CB LYS 4 1 Y 1 A CG LYS 3 A CG LYS 4 1 Y 1 A CD LYS 3 A CD LYS 4 1 Y 1 A CE LYS 3 A CE LYS 4 1 Y 1 A NZ LYS 3 A NZ LYS 4 1 Y 1 A CG GLN 4 A CG GLN 5 1 Y 1 A CD GLN 4 A CD GLN 5 1 Y 1 A OE1 GLN 4 A OE1 GLN 5 1 Y 1 A NE2 GLN 4 A NE2 GLN 5 1 Y 1 A CG1 ILE 5 A CG1 ILE 6 1 Y 1 A CD1 ILE 5 A CD1 ILE 6 1 Y 1 A CG LYS 8 A CG LYS 9 1 Y 1 A CD LYS 8 A CD LYS 9 1 Y 1 A CE LYS 8 A CE LYS 9 1 Y 1 A NZ LYS 8 A NZ LYS 9 1 Y 1 A CD LYS 15 A CD LYS 16 1 Y 1 A CE LYS 15 A CE LYS 16 1 Y 1 A NZ LYS 15 A NZ LYS 16 1 Y 1 A CG LYS 28 A CG LYS 29 1 Y 1 A CD LYS 28 A CD LYS 29 1 Y 1 A CE LYS 28 A CE LYS 29 1 Y 1 A NZ LYS 28 A NZ LYS 29 1 Y 1 B N MET 2 B N MET 3 1 Y 1 B CB MET 2 B CB MET 3 1 Y 1 B CG MET 2 B CG MET 3 1 Y 1 B SD MET 2 B SD MET 3 1 Y 1 B CE MET 2 B CE MET 3 1 Y 1 B CG LYS 3 B CG LYS 4 1 Y 1 B CD LYS 3 B CD LYS 4 1 Y 1 B CE LYS 3 B CE LYS 4 1 Y 1 B NZ LYS 3 B NZ LYS 4 1 Y 1 B CD1 ILE 5 B CD1 ILE 6 1 Y 1 B CB GLU 6 B CB GLU 7 1 Y 1 B CG GLU 6 B CG GLU 7 1 Y 1 B CD GLU 6 B CD GLU 7 1 Y 1 B OE1 GLU 6 B OE1 GLU 7 1 Y 1 B OE2 GLU 6 B OE2 GLU 7 1 Y 1 B CG LYS 8 B CG LYS 9 1 Y 1 B CD LYS 8 B CD LYS 9 1 Y 1 B CE LYS 8 B CE LYS 9 1 Y 1 B NZ LYS 8 B NZ LYS 9 1 Y 1 B CD GLU 10 B CD GLU 11 1 Y 1 B OE1 GLU 10 B OE1 GLU 11 1 Y 1 B OE2 GLU 10 B OE2 GLU 11 1 Y 1 B CD2 LEU 29 B CD2 LEU 30 1 Y 1 A ACE 0 A ACE 1 1 Y 1 A ARG 1 A ARG 2 1 Y 1 A ARG 33 A ARG 34 1 Y 1 B ACE 0 B ACE 1 1 Y 1 B ARG 1 B ARG 2 1 Y 1 B ARG 33 B ARG 34 1 Y 44.90 0.904 0.884 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. HIGH R-FREE BUT CONSISTENT WITH RELATED SEQUENCES IN SAME LATTICE. ELECTRON DENSITY MAPS ARE EXCELLENT. 0.319 0.282 0.284 1.90 56.52 326 6759 4.600 96.4 3.802 0.113 RANDOM 1 THROUGHOUT MOLECULAR REPLACEMENT 0.174 0.166 0.80 0.80 1.20 MAXIMUM LIKELIHOOD MASK 1.90 56.52 18 483 0 0 465 0.021 0.021 467 1.546 2.014 624 4.538 5.000 60 30.820 25.789 19 17.585 15.000 91 20.425 15.000 2 0.100 0.200 74 0.007 0.020 330 0.206 0.200 201 0.294 0.200 322 0.155 0.200 13 0.187 0.200 27 0.074 0.200 1 1.392 1.500 321 2.247 2.000 471 3.395 3.000 174 5.028 4.500 153 0.5420 0.4600 1.95 28 506 20 1.900 50.000 2CCE 7118 2.000 0.06000 1 20.6000 10.900 100.0 refinement REFMAC 5.2.0005 data reduction HKL-2000 data scaling HKL-2000 phasing PHASER GENERAL CONTROL PROTEIN GCN4 Parallel Configuration of pLI E20S 1 N N 1 N N 2 N N 2 N N A LYS 3 A LYS 4 HELX_P A LEU 30 A LEU 31 1 1 28 B LYS 3 B LYS 4 HELX_P B GLU 32 B GLU 33 1 2 30 FOUR HELIX BUNDLE FOUR HELIX BUNDLE, ANTIPARALLEL, PARALLEL, PLI, DNA-BINDING, NUCLEAR PROTEIN, TRANSCRIPTION, TRANSCRIPTION REGULATION, ACTIVATOR, AMINO-ACID BIOSYNTHESIS GCN4_YEAST UNP 1 249 P03069 RMKQLEDKVEELLSKNYHLENEVARLKKLVGER 249 281 2CCE 1 33 P03069 A 1 2 34 249 281 2CCE 1 33 P03069 B 1 2 34 1 acetylation ACE 0 2CCE A P03069 UNP 1 1 LEU engineered mutation ILE 5 2CCE A P03069 UNP 253 6 1 VAL engineered mutation LEU 9 2CCE A P03069 UNP 257 10 1 LEU engineered mutation ILE 12 2CCE A P03069 UNP 260 13 1 ASN engineered mutation LEU 16 2CCE A P03069 UNP 264 17 1 LEU engineered mutation ILE 19 2CCE A P03069 UNP 267 20 1 GLU engineered mutation SER 20 2CCE A P03069 UNP 268 21 1 VAL engineered mutation LEU 23 2CCE A P03069 UNP 271 24 1 LEU engineered mutation ILE 26 2CCE A P03069 UNP 274 27 1 VAL engineered mutation LEU 30 2CCE A P03069 UNP 278 31 2 acetylation ACE 0 2CCE B P03069 UNP 1 2 LEU engineered mutation ILE 5 2CCE B P03069 UNP 253 6 2 VAL engineered mutation LEU 9 2CCE B P03069 UNP 257 10 2 LEU engineered mutation ILE 12 2CCE B P03069 UNP 260 13 2 ASN engineered mutation LEU 16 2CCE B P03069 UNP 264 17 2 LEU engineered mutation ILE 19 2CCE B P03069 UNP 267 20 2 GLU engineered mutation SER 20 2CCE B P03069 UNP 268 21 2 VAL engineered mutation LEU 23 2CCE B P03069 UNP 271 24 2 LEU engineered mutation ILE 26 2CCE B P03069 UNP 274 27 2 VAL engineered mutation LEU 30 2CCE B P03069 UNP 278 31 213 P 41 3 2